Zobrazeno 1 - 10
of 138
pro vyhledávání: '"D, Bhella"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bingshu E. Chen, Lois E. Shepherd, Harriet Richardson, Donna E. Reece, Christopher P. Venner, Bethany Monteith, Joe Pater, Rodger E. Tiedemann, Vishal Kukreti, Matthew C. Cheung, Jill Dudebout, Hope Yen, Marc Lalancette, Chai Phua, Max Sherry, Annette E. Hay, Engin Gul, Vincent Castonguay, Sita D. Bhella
Publikováno v:
European Journal of Haematology. 107:333-342
Background The prevalence of multiple myeloma is increasing and there is a need to evaluate escalating therapy costs (Canadian Cancer Statistics A, 2020). The MYX.1 phase II trial showed that high-dose weekly carfilzomib, cyclophosphamide, and dexame
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fadb8a625d7030a13a0045d62878aa6d
https://doi.org/10.1111/ejh.13671
https://doi.org/10.1111/ejh.13671
Autor:
Ralph S. Baric, Mark T. Heise, H. Driscoll, J. Alexander, D. Bhella, C. Gold, C. D. Syme, Boyd Yount, Bryan A. Ballif, A. M. Schmoker, Jason Botten, Douglas G. Widman, P. Eisenhauer, C. M. Ziegler, E. Hutchinson, I. Manuelyan, D. Terino, J. I. Keller
Flaviviruses are enveloped, positive-strand RNA viruses that cause millions of infections in the human population annually. Although Zika virus (ZIKV) had been detected in humans as early as the 1950s, its reemergence in South America in 2015 resulte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12ada39f6f2454016b94630556443b75
https://doi.org/10.1101/2021.11.24.469793
https://doi.org/10.1101/2021.11.24.469793
Autor:
Michelle C. Lamarche, Wilma M. Hopman, Lois E. Shepherd, Angela Sirosky‐Yanyk, Danielle E. Hammond, Sita D. Bhella
Publikováno v:
Transfusion. 59:2308-2315
BACKGROUND Transfusion of 2 units of red blood cells (RBCs) for Hb ≤80 g/L is the prevailing liberal practice for patients undergoing intensive treatment for acute leukemia or hematopoietic transplant across North America. There is little evidence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34f61065d661f39aa18b83dbe6996f27
https://doi.org/10.1111/trf.15335
https://doi.org/10.1111/trf.15335
Autor:
Mehdi Hamadani, Bipin N. Savani, Taiga Nishihori, Jean Yi, Angela Scherwath, Melissa Gabriel, Mary E.D. Flowers, Ida Twist, Jason Law, Michael Byrne, Grzegorz W. Basak, Christopher Bredeson, Jane L. Liesveld, Hélène Schoemans, Susan K. Parsons, Minoo Battiwalla, Yoshiko Atsuta, Baldeep Wirk, James Gajewski, Zachariah DeFilipp, Jignesh Dalal, Robert J. Hayashi, Robert J. Soiffer, John P. Galvin, Adriana K. Malone, Andrew Daly, Sita D. Bhella, Ibrahim A. Ahmed, Hannah-Lise T. Schofield, Debra Lynch Kelly, Kehinde Adekola, Anne B. Warwick, Sara Beattie, Ami J. Shah, Jeffrey Auletta, Anuj Mahindra, Seema Naik, Robert Peter Gale, David Buchbinder, Nancy Bunin, Catherine J. Lee, Arnon Nagler, Jeff Szer, Rafael F. Duarte, Bronwen E. Shaw, Neel S. Bhatt, Maxim Norkin
Publikováno v:
Biology of Blood and Marrow Transplantation. 24:228-241
Hematopoietic cell transplantation (HCT) is a potentially curative treatment for children and adults with malignant and nonmalignant diseases. Despite increasing survival rates, long-term morbidity after HCT is substantial. Neurocognitive dysfunction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35aefcad18c2a98a0d520e3f91ea7b51
https://doi.org/10.1016/j.bbmt.2017.09.004
https://doi.org/10.1016/j.bbmt.2017.09.004
Autor:
James Gajewski, Zachariah DeFilipp, Nancy Bunin, Ibrahim Ahmed, Melissa Gabriel, John P. Galvin, Jeff Szer, Angela Scherwath, Jean Yi, M.E. Flowers, Hélène Schoemans, Minoo Battiwalla, Jane L. Liesveld, Hannah-Lise T. Schofield, Kehinde Adekola, Robert J. Soiffer, Rafael F. Duarte, Bronwen E. Shaw, Sita D. Bhella, Yoshiko Atsuta, Adriana K. Malone, Anne B. Warwick, Robert J. Hayashi, Bipin N. Savani, Jeffery J. Auletta, Mehdi Hamadani, Neel S. Bhatt, Andrew Daly, Baldeep Wirk, Catherine J. Lee, Arnon Nagler, Susan K. Parsons, Debra Lynch Kelly, Jignesh Dalal, Ida Twist, Anuj Mahindra, Maxim Norkin, Robert Peter Gale, Grzegorz W. Basak, Christopher Bredeson, David Buchbinder, Sara Beattie, Ami J. Shah, Seema Naik, Michael Byrne, Jason Law, Taiga Nishihori
Publikováno v:
Bone Marrow Transplantation. 53:535-555
Hematopoietic cell transplantation (HCT) is a potentially curative treatment for children and adults with malignant and non-malignant diseases. Despite increasing survival rates, long-term morbidity following HCT is substantial. Neurocognitive dysfun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5f1f444232e10e8fffe32d5fa465495
https://doi.org/10.1038/s41409-017-0055-7
https://doi.org/10.1038/s41409-017-0055-7
Publikováno v:
Biology of Blood and Marrow Transplantation. 23:1-4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::23673c5327aa8ef1c72200266582115b
https://doi.org/10.1016/j.bbmt.2016.12.410
https://doi.org/10.1016/j.bbmt.2016.12.410
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Pierre Villeneuve, Mitchell Sabloff, Sathish Kumar Gopalakrishnan, Natasha Kekre, Lothar Huebsch, Grace Christou, Sita D. Bhella, Mohamad Sobh, David S. Allan, Jill Fulcher, Mike Kennah, Sheryl McDiarmid, Alexandre P. Blanchard, Kelsey Maclellan, Harold L. Atkins, Ranjeeta Mallick, Nicole B. Laferriere, Christopher Bredeson, Sultan Altouri, Elisabeth Drouin
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S161
Introduction Busulfan (BU) has been used for approximatively four decades as a major component of chemotherapy-based conditioning before allo-HCT. At our center, IV-BU dose in MAC is 12.8 mg/kg (BU12.8) and in those not eligible for MAC, it is 9.6 mg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8644ff506af619655810d857a7f41595
https://doi.org/10.1016/j.bbmt.2019.12.715
https://doi.org/10.1016/j.bbmt.2019.12.715
Publikováno v:
Blood. 134:2136-2136
Background: Autologous stem cell transplantation (ASCT) as consolidation post induction is standard of care for eligible multiple myeloma patients. Multiple strategies are employed for mobilization of stem cells in ASCT. Cyclophosphamide/GCSF is an e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17be43cd7b7c636ff3dd8f1740b0a4a0
https://doi.org/10.1182/blood-2019-128819
https://doi.org/10.1182/blood-2019-128819